Compare
Abbott Laboratories vs Glaukos (ABT vs GKOS)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Abbott Laboratories (ABT) returned -11.7% and Glaukos (GKOS) +166.1%; so far this year the figures are -12.3% and +98.8%.
Abbott Laboratories is the larger company by market value, about 14.3 times the size of Glaukos.
Revenue grew +10.0% at ABT and +46.9% at GKOS over the last year.
ABT yields 2.29%. GKOS pays no dividend.
Data as of the latest close. Not investment advice.
Relative performance
| ABT | GKOS | |
|---|---|---|
| Price | $109.93 | $224.41 |
| 1-day | -3.23% | +2.01% |
| YTD | -12.26% | +98.75% |
| 1 year | -11.73% | +166.05% |
| 3 years | +15.70% | +223.22% |
| Market cap | $190.4B | $13.3B |
| P/E | 40.9 | — |
| P/S | 3.95 | 19.24 |
| P/B | 3.73 | 18.52 |
| Revenue growth | +10.00% | +46.90% |
| EPS growth | -66.20% | — |
| Gross margin % | 56.9 | 64.8 |
| Net margin % | 9.7 | -24.6 |
| ROE % | 9.2 | -23.7 |
| Debt / equity | 0.61 | 0.01 |
| FCF yield % | 3.5 | 0.3 |
| Dividend yield % | 2.29 | — |
| Beta | 0.06 | 1.04 |
| RSI (14) | 58.5 | 63.5 |
| Technical rating |